News & Updates

In vitro fertilization may increase prevalence of erectile, male sexual dysfunction
In vitro fertilization may increase prevalence of erectile, male sexual dysfunction
07 Oct 2021

The prevalence of erectile dysfunction is significantly higher among men participating in in vitro fertilization (IVF) in order to conceive compared to couples who conceived spontaneously, reveals a recent study. Such occurrence leads to a very high rate of phosphodiesterase-5 inhibitor use.

In vitro fertilization may increase prevalence of erectile, male sexual dysfunction
07 Oct 2021
Systemic diseases, smoking history linked to more severe dry eye signs
Systemic diseases, smoking history linked to more severe dry eye signs
07 Oct 2021 byStephen Padilla

Certain systemic diseases, such as Sjögren syndrome (SS), facial rosacea, rheumatoid arthritis (RA), and peripheral artery disease, and a history of daily cigarette smoking are significantly associated with more severe dry eye disease (DED) signs, a study has found.

Systemic diseases, smoking history linked to more severe dry eye signs
07 Oct 2021
Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
07 Oct 2021

In patients with acute coronary syndrome (ACS) or stable angina pectoris (SAP), undergoing noncardiac surgery after stenting increases the risk of myocardial infarction (MI), but only when procedures are performed during acute admission, a recent study has found.

Noncardiac surgery after stenting ups myocardial infarction risk in ACS, SAP patients
07 Oct 2021
Bicycling beneficial to patients with Parkinson’s disease
Bicycling beneficial to patients with Parkinson’s disease
07 Oct 2021

Patients with Parkinson’s disease may do well to ride a bicycle as this helps improve motor performance, especially crucial features of the gait, as reported in a study.

Bicycling beneficial to patients with Parkinson’s disease
07 Oct 2021
CV safety of degarelix vs leuprolide: Results remain inconclusive
CV safety of degarelix vs leuprolide: Results remain inconclusive
06 Oct 2021 byRoshini Claire Anthony

In men with prostate cancer and concomitant atherosclerotic cardiovascular disease (ASCVD), major adverse cardiovascular event (MACE) incidence did not differ between those who were treated with degarelix or leuprolide, according to findings of the PRONOUNCE trial.

CV safety of degarelix vs leuprolide: Results remain inconclusive
06 Oct 2021